Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.

Cardiovascular therapeutics - 1 Dec 2011

Kappelle Paul J W H, van Tol Arie, Wolffenbuttel Bruce H R, Dullaart Robin P F

Abstract excerpt

As delineated in this review, cholesteryl ester transfer protein (CETP) contributes to an atherogenic lipoprotein profile by redistributing cholesteryl esters from high density lipoprotein (HDL) toward apolipoprotein B-containing lipoproteins, especially when the concentration of acceptor triglyc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Cardiovascular Diseases
Share to Cholesterol Ester Transfer Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Dyslipidemias

Share to Evidence-Based Medicine

Share to Lipids

Share to Risk Assessment

Source

Identifiers

PMID: 20645987
DOI: 10.1111/j.1755-5922.2010.00201.x

Genes

CETP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20645987-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.PMID 20645987Read ↗

Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.Semantic proximity Read ↗

CETP inhibitors and cardiovascular disease: Time to think againSemantic proximity Read ↗

CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or Both.Semantic proximity Read ↗

Cholesteryl ester transfer protein: an enigmatic protein.Semantic proximity Read ↗

Cholesteryl Ester Transfer Protein (CETP) Variations in Relation to Lipid Profiles and Cardiovascular Diseases: An Update.Semantic proximity Read ↗

Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular DiseaseSemantic proximity Read ↗

Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular DiseaseSemantic proximity Read ↗

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular diseaseSemantic proximity Read ↗

Cholesteryl ester transfer protein: the controversial relation to atherosclerosis and emerging new biological roles.Semantic proximity Read ↗

Viability of developing CETP inhibitors.Semantic proximity Read ↗

Cholesterol ester transfer protein: a molecule with three faces?Semantic proximity Read ↗

Cholesteryl ester transfer protein and atherosclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.